It has been suggested that probiotics could reduce the incidence of infectious complications in patients with severe acute pancreatitis. This well-designed RCT showed an increased mortality in ...

Pancreatitis in children, often mistaken for minor digestive issues, can cause severe abdominal pain and requires timely ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.

USA: A study published in Digestive and Liver Disease suggests that youths who experience acute pancreatitis may face an ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a ...

The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic ...

Chronic pancreatitis, marked by persistent abdominal pain and compromised quality of life, is commonly treated with surgery or endoscopy. A randomised trial, initially conducted in the Netherlands ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults ...

APACHE II, Acute Physiology and Chronic Health Evaluation II; AUC, area under the ROC curve; BISAP, Beside Index for Severity in Acute Pancreatitis; ROC, receiver operating characteristics ...

US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...